Human CTLA-4 / B7-2 Inhibitor Screening Kit (TR-FRET)

This product is in development. If you are interested in this product, please contact us directly. We will accelerate our R&D process according to your needs and reserve the product for you.

Customer Reviews
Cat. No. / Size
Price
Qty
FRT-P053-100tests
$ 395.00
FRT-P053-500tests
$ 799.00

Product Details

  • Product Overview

    The Human CTLA-4 / B7-2 Inhibitor Screening Kit (TR-FRET) is based on a homogeneous (no wash) competition TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screen for inhibitors of human CTLA-4 binding to B7-2 within one hour. It can also be used as a universal detection tool to identify the ability of human CTLA-4 to bind to human B7-2.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Cytotoxic T-Lymphocyte-Associated Antigen 4

  • Category:

  • Approved Drugs:

    5 Details

  • Drugs in Clinical Trials:

    65 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Customer Reviews
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8